Autoimmune & Inflammatory Disorders

Autoimmune and inflammatory disorders arise when the immune system mistakenly targets host tissues or sustains uncontrolled inflammation. This area explores mechanisms leading to loss of tolerance, autoantibody production, and aberrant activation of T and B cells. Conditions such as rheumatoid arthritis, lupus, multiple sclerosis, and inflammatory bowel disease involve complex interactions between genetics, environment, microbiome imbalance, and dysregulated signaling pathways. Chronic inflammation is driven by cytokines, inflammasomes, and altered cellular communication that perpetuate tissue damage. Research focuses on identifying triggers, understanding immune checkpoints that fail, and mapping pathways that maintain tolerance. Advances in biologics, JAK inhibitors, and targeted therapies are transforming patient care. Scientists aim to refine biomarkers for early diagnosis, predict therapeutic response, and design interventions that restore immune equilibrium. Integrating molecular insights with clinical data is essential for developing personalized approaches to manage autoimmune and inflammatory diseases.

    Related Conference of Autoimmune & Inflammatory Disorders

    May 18-19, 2026

    17th Global Summit on Immunology and Cell Biology

    Paris, Aland Islands

    Autoimmune & Inflammatory Disorders Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in